F 11440, a potent, selective, high efficacy 5-HT(1A) receptor agonist with marked anxiolytic and antidepressant potential

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 1, 1998, Pages 266-283

  Koek, W ^a   Patoiseau, J F ^a   Assie, M B ^a   Cosi, C ^a   Kleven, M S ^a   Dupont Passelaigue, E ^a   Carilla Durand, E ^a   Palmier, C ^a   Valentin, J P ^a   John, G ^a   Pauwels, P J ^a   Tarayre, J P ^a   Colpaert, F C ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 METHYL 2 [4 (4 (PYRIMIDIN 2 YL)PIPERAZINO)BUTYL]2H,4H 1,2,4 TRIAZIN 3,5 DIONE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHISTAMINIC AGENT; BUSPIRONE; CORTICOSTERONE; DOPAMINE RECEPTOR BLOCKING AGENT; EMONAPRIDE; FLESINOXAN; KETANSERIN; MEPYRAMINE; MESULERGINE; METHOXAMINE; METHYLPHENIDATE; PRAZOSIN; SEROTONIN AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; DEPRESSION; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; MALE; NONHUMAN; OUTCOMES RESEARCH; PIGEON; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; COLUMBIDAE; CONFLICT (PSYCHOLOGY); CORTICOSTERONE; CYCLIC AMP; DOPAMINE ANTAGONISTS; FORSKOLIN; HELA CELLS; HUMANS; MALE; MICRODIALYSIS; PYRIMIDINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; TRIAZINES;

EID: 0032454063     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Ahlers ST, Weissman, BA and Barrett JE (1992) Antagonism studies with BMY-7378 and NAN-190: Effects on 8-hydroxy-2-(di-n-propylamino)tetralin-induced increases in punished responding of pigeons. J Pharmacol Exp Ther 260:474-481.
2. 1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties. Eur J Pharmacol 304:15-21.
3. 3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics. Eur J Pharmacol 237:183-189.
4. Ator NA and Griffiths RR (1986) Discriminative stimulus effects of atypical anxiolytics in baboons and rats. J Pharmacol Exp Ther 237:393-403.
5. Barrett JE and Vanover KE (1993) 5-HT receptors as targets for the development of novel anxiolytic drugs: Models, mechanisms and future directions. Psychopharmacology 112:1-12.
6. Barrett JE and Zhang L (1991) Anticonflict and discriminative stimulus effects of the 5-HT1A compounds WY-47,846 and WY-48,723 and the mixed 5-HT1A agonist/5-HT2 antagonist WY-50,324 in pigeons. Drug Develop Res 24:179-188.
7. Berendsen HHG, Bourgondien FGM and Broekkamp CLE (1994) Role of dorsal and medial raphe nuclei in lower lip retraction in rats. Eur J Pharmacol 263:315-318.
8. 1A receptors induces lower lip retraction in the rat. Pharmacol Biochem Behav 33: 821-827.
9. Boddeke HWGM, Fargin A, Raymond JR, Schoeffter P and Hoyer D (1992) Agonist/ antagonist interactions with cloned human 5-HT1A receptors - variations in intrinsic activity studied in transfected HeLa cells. Naunyn-Schmied Arch Pharmacol 345:257-263.
10. Borsini F and Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94:147-160.
11. Brocco MJ, Koek W, Degryse A-D and Colpaert FC (1990) Comparative studies on the antipunishment effects of chlordiazepoxide, buspirone and ritanserin in the pigeon, Geller-Seifter and Vogel conflict procedures. Behav Pharmacol 1:403-418.
12. Broekkamp CLE, Leysen D, Peeters BWMM and Pinder RM (1995) Prospects for improved antidepressants. J Med Chem 38:4615-4633.
13. Cervo L, Grignaschi G and Samanin R (1988) Different effects of intracerebral and systemic administration of buspirone in the forced swimming test: Involvement of a metabolite. Life Sci 43:2095-2102.
14. 1A agonist with exceptional anxiolytic potential. Drug Dev Res 26:21-48.
15. 1A receptor agonists: Recent developments and controversial issues. Psychopharmacology 121:1-26.
16. 1A receptors in psychopathology and the mechanism of action of clinically effective therapeutic agents. Drug News Perspectives 9(5):270-280.
17. 1A agonists in anxiety and depression. J Psychopharmacol 7:283-289.
18. Detke MJ, Rickels M and Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121:66-72.
19. 3H-mepyramine binding sites in guinea pig cerebellum and lung. Agents Actions 33:181-184.
20. Fargin A, Raymond JR, Regan JW, Cotecchia S and Lefkowitz RJ (1989) Effector coupling mechanisms of cloned 5-HT1A receptor. J Biol Chem 264:14848-14852.
21. 1A agonist. J Pharmacol Exp Ther 267:58-71.
22. 1A receptor agonists. Drug Dev Res 34:66-85.
23. Frazer A (1997) Pharmacology of antidepressants. J Clin Psychopharmacol 17: Suppl. 1: 2S-18S
24. Fulton B and Brogden RN (1997) Buspirone: An updated review of its clinical pharmacology and therapeutic applications. Cns Drugs 7:68-88.
25. Gleeson S Ahlers ST, Mansbach RS, Foust JM and Barrett JE (1989) Behavioral studies with anxiolytic drugs. VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes. J Pharmacol Exp Ther 250:809-817.
26. Greenblatt DJ, Shader RI and Abernethy DR (1983a) Current status of benzodiazpines. N Engl J Med 309:354-358.
27. Greenblatt DJ, Shader RI and Abernethy DR (1983b) Current status of benzodiazepines. N Engl J Med 309:410-416.
28. 1A properties of flesinoxan: In vivo electrophysiology and hypothermia study. Neuropharmacology 34:1311-1326.
29. 3H]ketanserin. Eur J Pharmacol 118:13-23.
30. Hubert JJ (1984) Bioassay. Kendall/Hunt, Dubuque, Iowa.
31. Kenakin TP (1993) Pharmacologic Analysis of Drug-Receptor Interaction. 2nd ed, Raven Press, New York, NY
32. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M and Blazer DG (1996) Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey. Br J Psychiatry 168:Suppl. 30:17-30.
33. 2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon. J Pharmacol Exp Ther 276:388-397.
34. 2 receptor antagonists to inhibit methylphenidate-induced behaviors in rats. Eur J Pharmacol 313:25-34.
35. Kleven M, Ybema C, Carilla E, Hamon M and Koek W (1995) Modification of behavioral effects of 8-hydroxy-2-(di-n-propylamino)tetralin after chronic ethanol consumption in the rat: Evidence for the involvement of 5-HT1A receptors in ethanol dependence. Eur J Pharmacol 281:219-228.
36. Koek W and Colpaert FC (1993) Inhibition of methylphenidate-induced behaviors in rats: Differences among neuroleptics. J Pharmacol Exp Ther 267:181-191.
37. Koek W, Kleven MS and Colpaert FC (1995): Effects of the NMDA antagonist, dizocilpine, in various drug discriminations: Characterization of intermediate levels of drug lever selection. Behav Pharmacol 6:590-600.
38. 1A autoreceptors of the dorsal and median raphe nuclei. J Pharmacol Exp Ther 269:1268-1279.
39. Leysen JE (1989) Use of 5-HT receptor agonists and antagonists for the characterization of their respective receptor sites. Drugs Tools Neurotransm Res 12:299-350.
40. 3H-ligand for serotonin2 receptor binding sites; binding properties, brain distribution and functional role. Mol Pharmacol 21:301-314.
41. Lucki I, Singh A and Kreiss DH (1994) Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci Biobehav Rev 18:85-95.
42. Mansbach RS, Harrod C, Hoffmann SM, Nader MA, Lei Z, Witkin JM and Barrett JE (1988) Behavioral studies with anxiolytic drugs. V. Behavioral and in vivo neurochemical analyses in pigeons of drugs that increase punished responding. J Pharmacol Exp Ther 246:114-120.
43. Marquardt DW (1963) An algorithm for least squares estimation of nonlinear parameters. J Soc Indust Appl Math 11:431.
44. 1A agonist. J Pharmacol Exp Ther 271:875-883.
45. 1C/2 antagonists as potential anxiolytic agents. In: Anxiety: neurobiology, clinical and therapeutical perspectives, ed. by M Hamon, H Ollat, M-H Thiebot, pp. 153-165. Colloque INSERM/John Libbey Eurotext, Vol. 232.
46. Millan MJ, Rivet J-M, Canton H, Lejeune F, Bervoets K, Brocco M, Gobert A, Deladonchamps BL, Lemarouille-Girardon S, Verriele L, Laubie M and Lavielle G (1992) S-14671 - A naphthylpiperazine 5-hydroxytryptamine(1A) agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine(1C/2) receptors. J Pharmacol Exp Ther 262:451-463.
47. 1A receptor agonists in the spontaneous tail-flick paradigm. J Pharmacol Exp Ther 269:121-131.
48. Möller HJ and VoIz HP (1996) Drug treatment of depression in the 1990s: An overview of achievements and future possibilities. Drugs 52:625-638.
49. Murphy BEP (1967) Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay. J Clin Endocr 27:973-990.
50. 1D receptor sites. Cell Pharmacol 2:183-191.
51. 1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells. Biochem Pharmacol 45:375-383.
52. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
53. Pollard GT, Nanry KP and Howard JL (1992) Effects of tandospirone in three behavioral tests for anxiolytics. Eur J Pharmacol 221:297-305.
54. Porsolt RD, Anton G, Blavet N and Jalfre M (1978) Behavioural despair in rats: A new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379-391.
55. Porsolt RD, McArthur RA and Lenegre A (1993) Psychotropic screening procedures. In: Methods in behavioral pharmacology, ed. by F van Haaren, pp. 23-51, Elsevier, Amsterdam, The Netherlands.
56. Przegalinski E, Budziszewska B, Warchol K and Blaszczynska E (1989) Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat. Pharmacology 33:329-334.
57. Przegalinski E, Tatarczynska E and Chojnacka-Wojcik E (1990) Antidepressant-like activity of ipsapirone, buspirone and gepirone in the forced swimming test in rats pretreated with proadifen. J Psychopharmacol 4:204-209.
58. Rickels K, Downing RW and Winokur A (1978) Antianxiety drugs: Clinical use in psychiatry. In: Handbook of Psychopharmacology, Volume 13, Biology of mood and antianxiety drugs, ed. by LL Iversen, SD Iversen, SH Snyder, pp. 395-430, Plenum Press, New York.
59. Rivet J-M, Millan MJ and Colpaert FC (1990) 8-OH-DPAT-induced corticosterone secretion as an in vivo model of 5- HT(1A) receptor function. Eur J Pharmacol 183:684-685.
60. Rocha e Silva M and Antonio A (1978) Bioassay of antihistaminic action. In: Histamine II and Antihistaminics, ed. by M Rocha e Silva, pp. 381-425, Springer-Verlag, Berlin.
61. Rosenbaum JF (1982) The drug treatment of anxiety. N Engl J Med 306:401-404.
62. Sanger DJ and Schoemaker H (1992) Discriminative stimulus properties of 8-OH-DPAT: Relationship to affinity for 5HT(1A) receptors. Psychopharmacology 108: 85-92.
63. Schipper J, Tulp MTM, Berkelmans B, Mos J, Vanderheijden JAM and Olivier B (1991) Preclinical pharmacology of flesinoxan: A potential anxiolytic and antidepressant drug. Hum Psychopharmacol Clin Exp 6:S53-S61.
64. 1A receptor agonists in the rat. J Pharmacol Exp Ther 266:572-579.
65. 1A receptor agonists 8-OH-DPAT and ipsapirone in the rat forced swimming test. Behav Pharmacol 4:625-636.
66. Sharp T and Hjorth S (1992) In vivo neurochemical studies of 5-HT1A autoreceptor function. Adv Biosci 85:297-323.
67. Siegel S and Castellan NJ Jr (1988) Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill, New York.
68. Signs SA and Schechter MD (1988) the role of dopamine and serotonin receptors in the mediation of the ethanol interoceptive cue. Pharmacol Biochem Behav 30:55-64.
69. 1A receptors. Neuropharmacolcgy 32:331-340.
70. Tallarida RJ and Murray RB (1987) Manual of Pharmacologic Calculations. Springer, New York.
71. Tricklebank MD (1985) The behavioural response to 5-HT receptor agonists and subtypes of the central 5-HT receptor. Trends Pharmacol Sci 14:403-407.
72. Tunnicliff G, Eison AS and Taylor DP (1991) Buspirone: Mechanisms and Clinical Aspects. Academic Press, San Diego.
73. Van Praag HM (1996) Serotonin-related, anxiety/aggression-driven, stressor-precipitated depression: A psycho-biological hypothesis. Eur Psychiatry 11:57-67.
74. 1-antihistamine compound. Arch Int Pharmacodyn 251:39-51.
75. Van Wijngaarden I, Tulp MTM and Soudijn W (1990) The concept of selectivity in 5-HT receptor research. Eur J Pharmacol - Mol Pharmacol Sect 188:301-312.
76. Wieland S and Lucki I (1990) Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test. Psychopharmacology 101:497-504.
77. Willner P (1989) Sensitization to the actions of antidepressant drugs. In: Psychoactive Drugs: Tolerance and Sensitization, ed. by AJ Goudie, MW Emmett-Oglesby, pp. 407-459, Humana Press, Clifton, New Jersey.
78. Winer BJ (1971) Statistical Principles in Experimental Design, 2nd ed, McGraw-Hill, New York.